Comorbidities and multi-organ injuries in the treatment of COVID-19.
作者信息
Wang Tianbing, Du Zhe, Zhu Fengxue, Cao Zhaolong, An Youzhong, Gao Yan, Jiang Baoguo
机构信息
Peking University People's Hospital, Beijing 100044, China.
Peking University People's Hospital, Beijing 100044, China.
出版信息
Lancet. 2020 Mar 21;395(10228):e52. doi: 10.1016/S0140-6736(20)30558-4. Epub 2020 Mar 11.
Abstract
摘要
相似文献
1
Comorbidities and multi-organ injuries in the treatment of COVID-19.新型冠状病毒肺炎治疗中的合并症与多器官损伤
Lancet. 2020 Mar 21;395(10228):e52. doi: 10.1016/S0140-6736(20)30558-4. Epub 2020 Mar 11.
2
Angiotensin receptor blockers for the treatment of COVID-19 and its comorbidities.用于治疗新型冠状病毒肺炎及其合并症的血管紧张素受体阻滞剂
Pharmacol Res. 2020 Sep;159:104958. doi: 10.1016/j.phrs.2020.104958. Epub 2020 May 28.
3
The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.新冠疫情期间羟氯喹短缺对皮肤病患者的影响。
Dermatol Ther. 2020 Jul;33(4):e13524. doi: 10.1111/dth.13524. Epub 2020 Jun 5.
4
[Thinking on clinical rational use of TCM injection in the treatment of novel coronavirus pneumonia (COVID-19)].关于中药注射剂治疗新型冠状病毒肺炎（COVID-19）临床合理应用的思考
Zhonghua Yi Xue Za Zhi. 2020 Apr 14;100(14):1044-1047. doi: 10.3760/cma.j.cn112137-20200221-00388.
5
Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).新冠肺炎危重症患者的静脉血栓栓塞症。
JAMA Netw Open. 2020 May 1;3(5):e2010478. doi: 10.1001/jamanetworkopen.2020.10478.
6
Just a little bit more patience….再耐心一点……
Anaesth Crit Care Pain Med. 2020 Jun;39(3):383-384. doi: 10.1016/j.accpm.2020.05.004. Epub 2020 May 13.
7
Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need.2019年冠状病毒病（COVID-19）治疗的临床试验：对迫切需求的快速响应。
Sci China Life Sci. 2020 May;63(5):774-776. doi: 10.1007/s11427-020-1660-2. Epub 2020 Feb 29.
8
On the use of corticosteroids for 2019-nCoV pneumonia.关于皮质类固醇在2019新型冠状病毒肺炎中的应用。
Lancet. 2020 Feb 29;395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.
9
The looming pandemic of COVID-19: What therapeutic options do we have now?新冠疫情的逼近：我们目前有哪些治疗选择？
J Chin Med Assoc. 2020 May;83(5):508-509. doi: 10.1097/JCMA.0000000000000310.
10
The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019.一例2019冠状病毒病感染病例的临床诊治过程。
J Med Virol. 2020 May;92(5):461-463. doi: 10.1002/jmv.25711. Epub 2020 Mar 1.
引用本文的文献
1
SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的开放阅读框7a（ORF7a）激活内皮细胞，使其释放血管性血友病因子，从而促进血栓形成。
Res Pract Thromb Haemost. 2025 Jun 20;9(4):102947. doi: 10.1016/j.rpth.2025.102947. eCollection 2025 May.
2
Discussion: COVID-19's impact on sports and athletes.讨论：2019冠状病毒病对体育和运动员的影响。
Ger J Exerc Sport Res. 2021;51(3):390-393. doi: 10.1007/s12662-021-00726-6. Epub 2021 Jun 28.
3
Effectiveness screening of SARS-CoV-2 (COVID-19) in the municipality of Andratx (Balearic Islands, Spain).西班牙巴利阿里群岛安达拉克斯市对严重急性呼吸综合征冠状病毒2（新冠病毒）的有效性筛查
Front Public Health. 2025 Apr 23;13:1461436. doi: 10.3389/fpubh.2025.1461436. eCollection 2025.
4
The Conditions of Survival of Patients with a SARS-CoV-2 Infection Burdened by Cardiovascular Pathologies in a Temporary Hospital in Gdańsk in 2021 and 2022.2021年和2022年格但斯克临时医院中感染SARS-CoV-2且伴有心血管疾病的患者的生存状况
J Clin Med. 2025 Apr 18;14(8):2806. doi: 10.3390/jcm14082806.
5
Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture.利用微流控亲和捕获技术对复杂生物流体中完整的新冠病毒颗粒进行超灵敏检测。
Sci Adv. 2025 Jan 10;11(2):eadh1167. doi: 10.1126/sciadv.adh1167.
6
New Insights into the Pleiotropic Actions of Dipeptidyl Peptidase-4 Inhibitors Beyond Glycaemic Control.二肽基肽酶-4抑制剂除血糖控制外的多效性作用新见解
touchREV Endocrinol. 2024 Oct;20(2):19-29. doi: 10.17925/EE.2024.20.2.5. Epub 2024 Sep 6.
7
IGSF1: a biomarker for predicting prognosis, immunotherapy response, and drug candidates in COVID-19 combined hepatocellular carcinoma.IGSF1：一种用于预测COVID-19合并肝细胞癌预后、免疫治疗反应及候选药物的生物标志物。
Discov Oncol. 2024 Oct 29;15(1):599. doi: 10.1007/s12672-024-01483-2.
8
SARS-CoV-2 impairs male fertility by targeting semen quality and testosterone level: A systematic review and meta-analysis.SARS-CoV-2 通过影响精液质量和睾丸酮水平损害男性生育能力：一项系统评价和荟萃分析。
PLoS One. 2024 Sep 9;19(9):e0307396. doi: 10.1371/journal.pone.0307396. eCollection 2024.
9
Vaccine challenges in CLL: a comprehensive exploration of efficacy of SARS-CoV-2 immunization for patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病的疫苗挑战：对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）免疫接种对慢性淋巴细胞白血病患者疗效的全面探索
Ann Hematol. 2024 Dec;103(12):4971-4980. doi: 10.1007/s00277-024-05869-8. Epub 2024 Jul 15.
10
Rationale for Randomized Clinical Trials Investigating the Potential of BCG Vaccination in Preventing COVID-19 Infection.研究卡介苗接种预防新型冠状病毒肺炎感染潜力的随机临床试验原理
Bladder Cancer. 2021 May 25;7(2):121-131. doi: 10.3233/BLC-201529. eCollection 2021.
本文引用的文献
1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病（COVID-19）疫情的流行病学特征 - 中国，2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
3
A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome.一种导致肺炎相关呼吸综合征的新型冠状病毒（2019 - 新型冠状病毒）
Cell Mol Immunol. 2020 May;17(5):554. doi: 10.1038/s41423-020-0372-4. Epub 2020 Feb 5.
4
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
5
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
Zotero 插件